Information date: 22 September 2026 — A wholly foreign-owned enterprise gives the investor full equity, a single-shareholder resolution process and no local partner, while a joint venture shares equity with a Chinese party in exchange for licences, land, distribution or government access. Both are limited liability companies registered with the market regulator, both sit behind the same negative list, and both are subject to the paid-in capital schedule introduced by the revised Company Law. Knowing that statement is not enough for an operating, research or compliance decision. The team must first establish who and what it applies to, how the effect reaches the real process, and which evidence would justify action.
Verified facts and scope
A wholly foreign-owned enterprise gives the investor full equity, a single-shareholder resolution process and no local partner, while a joint venture shares equity with a Chinese party in exchange for licences, land, distribution or government access. Both are limited liability companies registered with the market regulator, both sit behind the same negative list, and both are subject to the paid-in capital schedule introduced by the revised Company Law.
Compare structures only after confirming whether the activity is on the negative list and whether it appears in the encouraged catalogue, because that determines whether a Chinese partner is legally required or merely commercial. Then list what the partner actually brings: a licence you cannot obtain, land or a plant, retail shelf access, a state-owned customer relationship, or cash. Anything purchasable on the open market is not a reason to surrender equity.
How the effect reaches operations
Governance is allocated by the articles of association and the board, not by the share ratio alone, so a 51/49 split can still leave the foreign side unable to appoint the general manager or control the company seal and bank accounts. Where the partner supplies a regulated licence, that licence usually attaches to the Chinese entity, which reduces foreign leverage sharply if the relationship deteriorates.
Typical failures: using a JV to shortcut a sector where foreign equity is capped, then finding the same cap limits dividends and control; leaving deadlock, transfer pricing, non-compete and exit valuation unaddressed; and contributing technology without a written licence and payment trail. Divestment is slower in a JV because any buyer must satisfy both the Chinese shareholder and the regulator.
For “WFOE vs Joint Venture in China: Comparing Control, Capital and Exit Trade-offs”, official rules or published findings, direct evidence from the relevant product or process, and assumptions that remain untested should be recorded separately. A broad source defines the external boundary; it does not replace batch records, protocols, contracts, labels or direct observations.
Decision
Choose a WFOE unless the partner supplies a licence, land or demand that cannot be substituted within twelve months. Choose a JV when the partner's contribution is verifiable, escrowed and priced, and cap exposure through staged capital contributions tied to milestones. In either case, settle deadlock, transfer and valuation mechanics before signing, not during the first dispute.
Implementation checklist
- List what the partner contributes and price each item against market alternatives.
- Draft deadlock, transfer and valuation clauses before the feasibility report.
- Model the statutory capital contribution schedule against real operating cash flow.
- Assign one decision owner, one implementation owner and a dated review point for “WFOE vs Joint Venture in China: Comparing Control, Capital and Exit Trade-offs”.
- For “WFOE vs Joint Venture in China: Comparing Control, Capital and Exit Trade-offs”, archive the source page, access date, applicable population or entity, and internal evidence both supporting and opposing the current decision.
- When a rule, formulation, supplier, protocol or observed result changes, reopen only the affected question in “WFOE vs Joint Venture in China: Comparing Control, Capital and Exit Trade-offs”.
Evidence and review
For “WFOE vs Joint Venture in China: Comparing Control, Capital and Exit Trade-offs”, start with one real case rather than an abstract checklist. Record the input version, responsible owner, start time, observed result and stop condition. If the team cannot complete “List what the partner contributes and price each item against market alternatives.” with current evidence, it should not expand the process to more products, patients, suppliers or markets. The first review should focus only on facts capable of changing the decision.
The second control follows “Draft deadlock, transfer and valuation clauses before the feasibility report.”. Keep the source date, applicable population or entity, deadline, cost effect and owner in the same evidence file. A wording preference does not justify a new version. A repeated discrepancy, an unsupported health claim or a regulatory mismatch does: correct that point and hold release until the evidence is available.
After “Model the statutory capital contribution schedule against real operating cash flow.”, compare the intended outcome with what actually happened. Apply the same success criteria to each later expansion. If only one number, date or responsibility changes, update that field and the affected conclusion instead of recreating evidence that remains valid. This keeps the decision traceable without turning review into an open-ended rewrite cycle.
Limits of the conclusion
This comparison reflects general corporate and foreign investment frameworks and transition arrangements may apply to existing entities; it is not legal, tax or regulatory advice for any particular sector or transaction.
